Found: 7
Select item for more details and to access through your institution.
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination.
- Published in:
- Allergy, 2024, v. 79, n. 7, p. 1952, doi. 10.1111/all.16089
- By:
- Publication type:
- Article
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08298-6
- By:
- Publication type:
- Article
Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single‐centre, cluster randomized controlled trial.
- Published in:
- Contact Dermatitis (01051873), 2019, v. 80, n. 6, p. 365, doi. 10.1111/cod.13214
- By:
- Publication type:
- Article
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 9, p. 1305, doi. 10.1111/1346-8138.15939
- By:
- Publication type:
- Article
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The effects of systemic immunomodulatory treatments on COVID‐19 outcomes in patients with atopic dermatitis: Results from the global SECURE‐AD registry.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 365, doi. 10.1111/jdv.18613
- By:
- Publication type:
- Article
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 123, doi. 10.1111/jdv.18566
- By:
- Publication type:
- Article